Press Release
D.C. Circuit Grills DEA Over Years Long Delays as MMJ BioPharma Cultivation Demands Timely Ruling on Cannabis Grow
From Iowaska Church to MMJ BioPharma Cultivation, Appellate Courts Patience with DEA's Inaction Wears Thin Amid Constitutional Challenges. Administrator Terrance "Terry" Cole must issue a final order "as soon as practicable." The Administrative Procedure Act likewise requires agencies to "proceed to conclude a matter presented to [them]" within a reasonable time. Read More
Press Release
Compassion Center, the Las Vegas Community, and Loved Ones Honor the Life and Immeasurable Legacy of Julie "Nurse Juhlzie" Monteiro with Community Celebrations December 13-14, 2025
It is with the greatest of sadness and the deepest of regret that Compassion Center announces the passing of its most beloved, precious, fearless, and courageous leader, Julie "Nurse Juhlzie" Monteiro (Creel), who peacefully transitioned of natural causes on November 11th, 2025, in the comfort, warmth, and sanctuary of her cozy king-sized bed. Read More
Press Release
Kultura Brands (OTC:LTNC) Announces Official Launch Elevate Health & Wellness Gummies
KULTURA BRANDS (OTCID: LTNC) ANNOUNCES OFFICIAL LAUNCH ELEVATE HEALTH & WELLNESS GUMMIES NOW AVAILABLE FOR B2B THROUGH CENCORA MARKETPLACE AND DIRECT-TO-CONSUMER AT LOCKDIN.COM; THIRST RESPONDER HYDRATION LAUNCHES MID-DECEMBER; PORTION OF ALL SALES BENEFITS THE MANNY PACQUIAO FOUNDATION Read More
Press Release
Ondas Secures $8.2 Million Order from Major European Security Agency to Protect One of Europe's Largest Airports with Multiple Iron Drone Raider Systems
Ondas' Airobotics subsidiary to serve as prime contractor on the multi-system autonomous counter-UAS deployment delivering 24/7 protection for critical air infrastructure Recent incidents across Europe, where drone intrusions forced flight suspensions, have highlighted the urgent need for effective and reliable counter-drone solutions The order marks another milestone in a record year for Ondas, following record-high bookings and revenues and the execution of multiple strategic acquisitions expanding its autonomous defense portfolio Read More
Press Release
IGC Pharma Reports Accelerated Q2 Progress and Strengthened Financial Focus: CALMA Trial Passes 50% Enrollment Milestone, Strategic Divestiture Optimizes Capital
Company Accelerates Phase 2 Alzheimer's Program and Gains National Institute on Aging (NIA) Recognition for AI Leadership Read More
Press Release
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure due to microvillus inclusion disease (MVID), reducing the volume of the total parenteral support (PS) necessary for them to survive, though with associated toxicity; Groundbreaking PS reduction of up to 37%; No approved treatments exist for MVID Company completed meeting with FDA October 2, 2025 for advice on possible expedited approval pathway to advance its ongoing placebo-controlled trial of crofelemer for potential approval for treatment of MVID REMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q3 2025 financials and company updates; Click here to register Read More
Press Release
XCF Global and BGN Developing Global Distribution and Logistics Partnership
Strategic partnership between XCF Global and BGN to jointly develop global distribution and logistics infrastructure for SAF and other renewable fuels Seeks to expand XCF's international reach into key markets including Europe and the Middle East through production, offtake, and co-branded distribution agreements Advances global renewable fuel supply chains to meet rapidly rising demand for SAF Read More
Press Release
Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health impact, unmet medical need, access, affordability, domestic manufacturing and rare-disease alignment. Read More
Press Release
EON Resources Inc. Announces 3rd Quarter 2025 Earnings Call to be held Tuesday, November 18, 2025
Management Will Be Discussing Its Financial Results, Sources and Uses of Funding of $40.5 Million Closed on September 9, 2025, and Accomplishments and Plans for the Remainder of 2025 Read More
Press Release
EON Resources Inc. Reports Results for the Third Quarter of 2025
Record Net Income of $5.6 Million for the Quarter; Retired All $41 Million of Senior and Seller Debt; Retired All Preferred Shares with Redemption Value of $27 Million; and Increased Shareholder Equity by $22.7 Million Read More
Press Release
President Trumps Cannabis Decision Soon: From Hemp Shutdown to Pharmaceutical Clarity: MMJ Leads Federally Legal Cannabis Drug Development
"The federal hemp crackdown has created long overdue pharmaceutical clarity. MMJ is now the company advancing a fully compliant cannabinoid drug program under FDA and DEA oversight," noted Duane Boise, CEO MMJ International Holdings. "Drug development allows for no shortcuts. It demands consistency, validation, and adherence to federal law." Read More
Press Release
Best Silver IRA Companies in the US (Top Silver IRA Rollover Companies Ranked)
IRAEmpire has published its new and updated rankings of the best silver IRA providers in the USA this year. The rankings are aimed at educating consumers to help them make better-informed decisions. Read More
Press Release
Ensysce Biosciences Reports Third Quarter 2025 Financial Results
~ Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to Novel Opioid Solutions ~ ~ Further Program Advancement Supported by Preferred Stock Financing ~ Read More
Press Release
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
- Dermata announced a strategic pivot to develop and commercialize over-the-counter (OTC) skin care treatments - - Dermata plans to launch its first OTC product, a once weekly acne kit with its Spongilla technology, in the middle of 2026 - Read More
Press Release
Tom Brady 1/1 NFL Shield Autograph Card Hits Fanatics Collect Premier Auction Through Medical Care Technologies Inc. (OTC PINK:MDCE) Subsidiary Infinite Auctions
With 6-figure expectations this one of one 2009 Topps Unique Tom Brady card featuring a game-worn NFL Equipment patch and autograph is now live at Fanatics Collect's Premier Auction that ends Thursday, November 20, 2025 at 9:30 PM Eastern Time (EST). Read More
Press Release